CAR-T cell Clinical Trials

4 actively recruiting trials across 3 locations

Also known as: CAR-T cell therapy

Filter by location:

Other1 trial

Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

Phase 1/2

Bethesda, Maryland1 trial

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

National Institutes of Health Clinical Center

Phase 1

Basking Ridge, New Jersey1 trial

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)

Early 1

Dallas, Texas1 trial

Study of IOMAB-ACT Followed by CAR-T Cell Therapy for Patients Relapsed or Refractory (Diffuse Large B-cell Lymphoma

University of Texas Southwestern Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.